Skip to main content

Tesamorelin vs Hexarelin

Both Tesamorelin and Hexarelin are used for growth-hormone. Here's how their evidence, dosing, and regulatory status actually compare.

Tesamorelin

Evidence A

Tesamorelin (Egrifta)

An FDA-approved GHRH analog that stimulates natural growth hormone production. Clinically proven to reduce visceral adipose tissue and increasingly used off-label for body recomposition.

View full Tesamorelin profile →

Hexarelin

Evidence B

Hexarelin (HEX)

The strongest GH-releasing hexapeptide and one of the few peptides with documented direct cardiac benefits in animal models. Tachyphylaxis (diminished response over time) limits long-term use.

View full Hexarelin profile →

Side-by-Side

AttributeTesamorelinHexarelin
Evidence GradeAB
FDA StatusFDA-approved for HIV-associated lipodystrophyNot FDA-approved — research compound (cardioprotective signals investigated)
Typical Dose2 mg daily (subcutaneous)100 mcg, 1–2 times daily (subcutaneous)
Clinics Indexed17841
Categoriesgrowth-hormone, fat-lossgrowth-hormone, recovery

Key reported benefits — Tesamorelin

  • Visceral fat reduction
  • Natural GH stimulation
  • Cognitive benefit
  • Lean mass

Key reported benefits — Hexarelin

  • Strongest GH spike of GHRPs
  • Cardioprotective signals
  • Recovery

Educational use only

This comparison is for educational purposes and not medical advice. Peptide selection should be made with a licensed medical professional based on your individual goals, health history, and current evidence quality.

← Back to all comparisons